CN104013836A - 一种治疗脑中风后遗症的中药组合物 - Google Patents
一种治疗脑中风后遗症的中药组合物 Download PDFInfo
- Publication number
- CN104013836A CN104013836A CN201410294414.XA CN201410294414A CN104013836A CN 104013836 A CN104013836 A CN 104013836A CN 201410294414 A CN201410294414 A CN 201410294414A CN 104013836 A CN104013836 A CN 104013836A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 208000006011 Stroke Diseases 0.000 title claims abstract description 27
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 26
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 241000131808 Scolopendra Species 0.000 claims description 11
- 241000522620 Scorpio Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 241000237636 Pheretima Species 0.000 claims description 8
- 241000208966 Polygala Species 0.000 claims description 5
- 241000219780 Pueraria Species 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 5
- 239000009490 scorpio Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000001717 pathogenic effect Effects 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 35
- 210000004369 blood Anatomy 0.000 description 34
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 2
- 229960003009 clopidogrel Drugs 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 229960000715 nimodipine Drugs 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010050012 Bradyphrenia Diseases 0.000 description 1
- 206010007687 Carotid artery stenosis Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000004404 Intractable Pain Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010027295 Menometrorrhagia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000006170 carotid stenosis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229960004526 piracetam Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410294414.XA CN104013836B (zh) | 2014-06-26 | 2014-06-26 | 一种治疗脑中风后遗症的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410294414.XA CN104013836B (zh) | 2014-06-26 | 2014-06-26 | 一种治疗脑中风后遗症的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104013836A true CN104013836A (zh) | 2014-09-03 |
CN104013836B CN104013836B (zh) | 2016-11-23 |
Family
ID=51431019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410294414.XA Expired - Fee Related CN104013836B (zh) | 2014-06-26 | 2014-06-26 | 一种治疗脑中风后遗症的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104013836B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104338052A (zh) * | 2014-09-29 | 2015-02-11 | 赵霞 | 治疗脑血栓的中药配方 |
CN109453330A (zh) * | 2018-12-21 | 2019-03-12 | 周多强 | 一种治疗脑梗后认知功能障碍的中药制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1385206A (zh) * | 2002-06-05 | 2002-12-18 | 王洪臣 | 中风脑心通 |
CN101002899A (zh) * | 2007-01-11 | 2007-07-25 | 许新华 | 偏瘫脑络康纯中草药剂 |
-
2014
- 2014-06-26 CN CN201410294414.XA patent/CN104013836B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1385206A (zh) * | 2002-06-05 | 2002-12-18 | 王洪臣 | 中风脑心通 |
CN101002899A (zh) * | 2007-01-11 | 2007-07-25 | 许新华 | 偏瘫脑络康纯中草药剂 |
Non-Patent Citations (2)
Title |
---|
王旭: "中风病辨治体会", 《实用中医药杂志》 * |
高分飞等: "中风后遗症的中药治疗近况", 《现代诊断与治疗》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104338052A (zh) * | 2014-09-29 | 2015-02-11 | 赵霞 | 治疗脑血栓的中药配方 |
CN109453330A (zh) * | 2018-12-21 | 2019-03-12 | 周多强 | 一种治疗脑梗后认知功能障碍的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104013836B (zh) | 2016-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101721664A (zh) | 一种治疗中风偏瘫及全身瘫痪的中药 | |
CN103550517B (zh) | 一种治疗肝癌的药物 | |
CN102793822B (zh) | 一种治疗阑尾炎的药物及其制备方法 | |
CN103751570B (zh) | 一种内服治疗偏头痛的中药 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN101716299B (zh) | 一种治疗乳腺增生的中药组合物 | |
CN103120766B (zh) | 一种治疗高血压的中药组合物 | |
CN104043054A (zh) | 一种治疗中风后遗症的药物 | |
CN102626449A (zh) | 一种治疗中风偏瘫的胶囊 | |
CN104258289A (zh) | 一种治疗肠炎的中药 | |
CN103550539B (zh) | 一种治疗高血压的中药组合物 | |
CN103585453B (zh) | 一种治疗高血压的中药 | |
CN104013836B (zh) | 一种治疗脑中风后遗症的中药组合物 | |
CN102671147B (zh) | 一种治疗脑血栓的中药组合物 | |
CN104645078A (zh) | 一种治疗偏头痛的中药组合物 | |
CN104189786A (zh) | 一种治疗风湿性心脏病的中药 | |
CN103202985A (zh) | 治疗腰椎、颈椎、坐骨神经、风湿病的中药及其制备方法 | |
CN105521473A (zh) | 一种治疗小儿麻痹后遗症的药物及其制备方法 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN104162026A (zh) | 治疗高血压的中药组合物及其制备方法 | |
CN104288596A (zh) | 一种治疗强直性脊柱炎的中药组合物 | |
CN106310137A (zh) | 一种治疗冠心病心绞痛气滞血瘀证的中药组合物 | |
CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
CN104306943A (zh) | 一种治疗高血脂症的中药组合物 | |
CN105106761A (zh) | 一种治疗脊髓损伤的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Cheng Lvfang Inventor after: Yang Xiaohong Inventor after: Mo Nan Inventor after: Chen Xiaoyong Inventor before: Wang Fen |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160922 Address after: 450000 Henan province Zheng Dong New District of Zhengzhou City College Road and Goldwater Longzihu District wise Road intersection Applicant after: Henan University of Traditional Chinese Medicine Address before: Wangzhuangcun Messire town of Zhangqiu city 250200 Ji'nan City, Shandong Province Applicant before: Wang Fen |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161123 Termination date: 20180626 |
|
CF01 | Termination of patent right due to non-payment of annual fee |